Life Extension Spring Clearance Sale

Endometrial Cancer

References

A.D.A.M. Medical Encyclopedia. Endometrial cancer. PubMed Health web page. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001908. 2012. Accessed 8/21/2013.

Acharya S, Hensley ML, Montag AC, et al. Rare uterine cancers. Lancet Oncol. 2005 Dec;6(12):961-71.

ACS. American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society; 2013a.

ACS. American Cancer Society. Treatment options for endometrial cancer by stage. Updated 1/17/2013b. Available at: http://www.cancer.org/cancer/endometrialcancer/detailedguide/endometrial-uterine-cancer-treating-by-stage. Accessed 8/30/2013.

Agarwal VR, Ashanullah CI, Simpson ER, et al. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. J Clin Endocrinol Metab. 1997 Jan;82(1):70-4.

Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell cycle (Georgetown, Tex.). Sep 2005;4(9):1201-1215.

Aghajanian C, Sill MW, Darcy KM, Greer B, McMeekin DS, Rose PG, . . . Leslie KK. Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Jun 1 2011;29(16):2259-2265.

Ahn WS, Kim DJ, Chae GT, Lee JM, Bae SM, Sin JI, . . . Lee IP. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. Jul-Aug 2004;14(4):589-594.

Akram T, Maseelall P, Fanning J. Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer. Am J Obstet Gynecol. 2005 May;192(5):1365-7.

Allen NE, Key TJ, Dossus L, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2008;15(2):485-97.

Altomare R, Cacciabaudo F, Damiano G, Palumbo VD, Gioviale MC, Bellavia M, . . . Lo Monte AI. The mediterranean diet: a history of health. Iranian journal of public health. 2013;42(5):449-457.

Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. Aug 6-12 2005;366(9484):491-505.

Apgar BS, Greenberg G. Using progestins in clinical practice. American family physician. Oct 15 2000;62(8):1839-1846, 1849-1850.

Arem H, Neuhouser ML, Irwin ML, Cartmel B, Lu L, Risch H, . . . Yu H. Omega-3 and omega-6 fatty acid intakes and endometrial cancer risk in a population-based case-control study. Eur J Nutr. Aug 23 2012.

Arora V, Quinn MA. Endometrial cancer. Best Pract Res Clin Obstet Gynaecol. Jun 2012;26(3):311-324.

Avberšek M, Sömen J, Heath E. Dynamics of steroid estrogen daily concentrations in hospital effluent and connected waste water treatment plant. J Environ Monit. 2011 Aug;13(8):2221-6.

Baak JP, Mutter GL, Robboy S, van Diest PJ, Uyterlinde AM, Orbo A, . . . Verheijen RH. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. Jun 1 2005;103(11):2304-2312.

Baker TR. Clinical Key. First Consult; Uterine cancer. 2007; www.clinicalkey.com. Accessed 7/18/2013.

Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, et al. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008 Jan;83(1):97-112

Bandera EV, Gifkins DM, Moore DF, McCullough ML, Kushi LH. Antioxidant vitamins and the risk of endometrial cancer: a dose-response meta-analysis. Cancer Causes Control. Jul 2009;20(5):699-711.

Banno K, Kisu I, Yanokura M, Tsuji K, Masuda K, Ueki A, . . . Aoki D. Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review). Int J Oncol. Jun 2012;40(6):1755-1762.

Barrenetxe J, Delagrange P, Martinez JA. Physiological and metabolic functions of melatonin. J Physiol Biochem. Mar 2004;60(1):61-72.

Batra S, Bengtsson LP, Grundshell H, et al. Levels of free and protein-bound progesterone in plasma during late pregnancy. J Clin Endocrinol Metab. 1976 Jun;42(6):1041-7.

Beral V, Bull D, Reeves G, Million Women Study C. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet. Apr 30-May 6 2005;365(9470):1543-1551.

Bergman Jungestrom M, Thompson LU, Dabrosin C. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clinical cancer research : an official journal of the American Association for Cancer Research. Feb 1 2007;13(3):1061-1067.

Bernstein L, Deapen D, Cerhan JR, et al. Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst. 1999 Oct 6;91(19):1654-62.

Berstein L, Tsyrlina E, Poroshina T, Bychkova N, Kalinina N, Gamajunova V, . . . Kovalenko I. Switching (overtargeting) of estrogen effects and its potential role in hormonal carcinogenesis. Neoplasma. 2002;49(1):21-25.

Berstein LM, Kvatchevskaya JO, Poroshina TE, Kovalenko IG, Tsyrlina EV, Zimarina TS, . . . Thijssen JH. Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol. Nov 2004;130(11):687-693.

Bhat KP, Pezzuto JM. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. Cancer Res. 2001;61(16):6137-44.

Bidard F-C, Ligthart ST, Decraene C, et al. P4-07-09: Automated Quantitative Assessment of HER2 Expression of Circulating Tumor Cells (CTC) in Metastatic Breast Cancer (IC 2006-04 Study). Poster Session 4 – Detection and Diagnosis – Pathology: Circulating Tumor Cells. Cancer Res. 2011;71(24 Suppl): P4-07-09.

Biel RK, Csizmadi I, Cook LS, Courneya KS, Magliocco AM, Friedenreich CM. Risk of endometrial cancer in relation to individual nutrients from diet and supplements. Public Health Nutr. Nov 2011;14(11):1948-1960.

Biofocus. Biofocus (Germany). Molecular Oncology. Directory of Services (2011). Available at: http://www.biofocus.de/PDF/Onkologie/BF_111_Brochure_M-Oncology.pdf 2011.

Boshuizen R, Kuhn P, van den Heuvel M. Circulating tumor cells in non-small cell lung carcinoma. J Thorac Dis. 2012 Oct;4(5):456-8.

Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. 2-hydroxyestrone: the 'good' estrogen. The Journal of endocrinology. Sep 1996;150 Suppl:S259-265.

Bradlow HL. Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer. In vivo (Athens, Greece). Jul-Aug 2008;22(4):441-445.

Brinton LA, Sakoda LC, Frederiksen K, Sherman ME, Kjaer SK, Graubard BI, . . . Mellemkjaer L. Relationships of uterine and ovarian tumors to pre-existing chronic conditions. Gynecologic oncology. Dec 2007;107(3):487-494.

Brtko J, Thalhamer J. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention. Current pharmaceutical design. 2003;9(25):2067-2077.

Bulun SE, Simpson ER. Competitive RT-PCR analysis indicates levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. J Clin Endocrinol Metab 1988;7:1379-85.

Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, . . . Lu KH. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol. Apr 2011;204(4):355 e351-357.

Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. Mar 2010;2(3):355-374.

Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy. Gynecologic oncology. Jan 2010;116(1):92-98.

Carlson MJ, Thiel KW, Yang S, Leslie KK. Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer. Discovery medicine. Sep 2012;14(76):215-222.

Cavalli LR, Urban CA, Dai D, et al. Genetic and epigenetic alterations in sentinel lymph notes metastatic lesions compared to their corresponding primary breast tumors. Cancer Genet Cytogenet. 2003; 146(1):33-40.

Cederroth CR, Nef S. Soy, phytoestrogens and metabolism: A review. Mol Cell Endocrinol. May 25 2009;304(1-2):30-42.

Ciszko B, Zdrojewicz Z. [Compliance endogenous and exogenous estriol in clinical practice]. Ginekol Pol. 2006 Jul;77(7):559-65.

Clarke CL, Sutherland RL. Progestin regulation of cellular proliferation. Endocr Rev. May 1990;11(2):266-301.

Cleland WH, Mendelson CR, Simpson ER. Effects of aging and obesity on aromatase activity of human adipose cells. J Clin Endocrinol Metab 1985;60:174-7.

Cohen SJ, Punt CJ, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008 Jul 1;26(19):3213-21.

Creasman WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer. Feb 15 1993;71(4 Suppl):1467-1470.

Creutzberg CL, Nout RA. The role of radiotherapy in endometrial cancer: current evidence and trends. Curr Oncol Rep. 2011;13(6):472-8.

Cristofanilli M, Broglio KR, Guarneri V, Jackson S, Fritsche HA, Islam R, . . . Valero V. Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clinical breast cancer. Feb 2007;7(6):471-479.

Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, . . . Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. The New England journal of medicine. Aug 19 2004;351(8):781-791.

Cunzhi H, Jiexian J, Xianwen Z, Jingang G, Shumin Z, Lili D. Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma. Biological trace element research. Aug 2003;94(2):113-122.

Cust AE. Physical activity and gynecologic cancer prevention. Recent Results Cancer Res. 2011;186:159-185.

Dai D, Albitar L, Nguyen T, et al. A therapeutic model for advanced endometrial cancer: systemic progestin in combination with local adenoviral-mediated progesterone receptor expression. Mol Cancer Ther. 2005 Jan;4(1):169-75.

Dai D, Wolf DM, Litman ES, White MJ, Leslie KK. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer research. Feb 1 2002;62(3):881-886.

Dalvi TB, Canchola AJ, Horn-Ross PL. Dietary patterns, Mediterranean diet, and endometrial cancer risk. Cancer causes & control : CCC. Nov 2007;18(9):957-966.

Dann JM, Sykes PH, Mason DR, et al. Regulation of Vascular Endothelial Growth Factor in endometrial tumor cells by resveratrol and EGCG. Gynecol Oncol. 2009;113(3):374-8.

Darb-Esfahani S, Wirtz RM, Sinn BV, et al. Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue. Endocr Relat Cancer. 2009 Dec;16(4):1129-39.

Decensi A, Fontana V, Bruno S, et al. Effect of tamoxifen on endometrial proliferation. J Clin Oncol. 1996 Feb; 14(2):434-40.

Denschlag D, Ulrich U, Emons G. The diagnosis and treatment of endometrial cancer: progress and controversies. Deutsches Arzteblatt international. Aug 2010;108(34-35):571-577.

Dong X, Alpaugh KR, Cristofanilli M. Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu. Dec 2012;24(4):388-398.

Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR. Trends in endometrial cancer incidence rates in the United States, 1999-2006. J Womens Health (Larchmt). Aug 2011;20(8):1157-1163.

Duska LR, Berkowitz R, Matulonis U, et al. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with “high-risk” endometrial cancer. Gynecol Oncol. 2005 Jan;96(1):198-203.

El-Sahwi KS, Schwartz PE, Santin AD. Development of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer. Expert Rev Anticancer Ther. Jan 2012;12(1):41-49.

Emons G, Heyl W. Hormonal treatment of endometrial cancer. J Cancer Res Clin Oncol. Nov 2000;126(11):619-623.

Evans JM, Donnelly LA, Emslie-Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330:1304–1305.

Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecologic oncology. Jul 2009;114(1):121-127.

Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents. Nature reviews. Drug discovery. Aug 2006;5(8):671-688.

Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nature reviews. Drug discovery. May 2004;3(5):391-400.

Fram KM, Sumrein IM. Laparoscopic versus abdominal hysterectomy in the treatment of endometrial cancer. Saudi medical journal. Jan 2013;34(1):11-18.

Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Feb 2007;16(2):276-280.

Friberg E, Orsini N, Mantzoros CS, et al. Coffee drinking and risk of endometrial cancer--a population-based cohort study. Int J Cancer. 2009 Nov 15;125(10):2413-7.

Friberg E, Wallin A, Wolk A. Sucrose, high-sugar foods, and risk of endometrial cancer--a population-based cohort study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Sep 2011;20(9):1831-1837.

Fujimoto J, Sato E. Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers. J Steroid Biochem Mol Bol. 2009 Aug;116(1-2):71-5.

Fukuda K, Mori M, Uchiyama M, et al. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecol Oncol. 1998 Jun;69(3):220-5.

Galizia G, Gemei M, Orditura M, Romano C, Zamboli A, Castellano P, . . . Lieto E. Postoperative Detection of Circulating Tumor Cells Predicts Tumor Recurrence in Colorectal Cancer Patients. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. Jun 28 2013.

Galuska D, Nolte LA, Zierath JR, Wallberg-Henriksson H. Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM. Diabetologia. Aug 1994;37(8):826-832.

Gazzaniga P, Gianni W, Raimondi C, Gradilone A, Lo Russo G, Longo F, Gandini O, Tomao S, Frati L. Circulating tumor cells in high-risk nonmetastatic colorectal cancer. Tumour Biol. 2013 Mar 29.

Genkinger JM, Friberg E, Goldbohm RA, et al. Long-term dietary heme iron and red meat intake in relation to endometrial cancer risk. Am J Clin Nutr. 2012 Oct;96(4):848-54.

Giri A, Sturgeon SR, Luisi N, et al. Caffeinated coffee, decaffeinated coffee and endometrial cancer risk: a prospective cohort study among US postmenopausal women. Nutrients. 2011 Nov;3(11):937-50.

Giudice LC. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best practice & research. Clinical endocrinology & metabolism. Jun 2006;20:235-244.

Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, Kolonel LN. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer research. Nov 15 1997;57(22):5077-5085.

Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption with the risk of endometrial cancer. American journal of epidemiology. Aug 15 1997;146(4):294-306.

Goodsell DS. The molecular perspective: tamoxifen and the estrogen receptor. Oncologist. 2002;7(2):163-4.

Grushko TA, Filiaci VL, Mundt AJ, Ridderstrale K, Olopade OI, Fleming GF, Gynecologic Oncology G. An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecologic oncology. Jan 2008;108(1):3-9.

Gunter MJ, Schaub JA, Xue X, et al. A prospective investigation of coffee drinking and endometrial cancer incidence. Int J Cancer. 2012 Aug 15;131(4):E530-6.

Gupta M, McDougal A, Safe S. Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. The Journal of steroid biochemistry and molecular biology. Dec 1998;67(5-6):413-419.

Hadziabdić MO, Bozikov V, Pavić E, et al. The antioxidative protecting role of the Mediterranean diet. Coll Antropol. 2012 Dec;36(4):1427-34.

Hamilton CA, Cheung MK, Osann K, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrial corpus cancers. Br J Cancer. 2006 Mar;94(5):642-6.

Hartman J, Strom A, Gustafsson JA. Estrogen receptor beta in breast cancer—diagnostic and therapeutic implications. Steroids. 2009 Aug;74(8):635-41.

Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. Aug 15 2004;18(16):1926-1945.

Hayashi SI, Eguchi H, Tanimoto K, et al. he expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr Relat Cancer. 2003 Jun;10(2):193-202.

Hemsell DL, Grodin JM, Brenner PF, et al. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab. 1974;38:476-9.

Hesselius I, Johansson ED. Medroxyprogesterone acetate (MPA) plasma levels after oral and intramuscular administration in a long-term study. Acta Obstet Gynecol Scand Suppl. 1981;101:65-70.

Hetzel DJ, Wilson TO, Keeney GL, et al. HER-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol. 1992 Nov;47(2):179-85.

Hinkula M, Pukkala E, Kyyrönen P, et al. Grand multiparity and incidence of endometrial cancer: a population-based study in Finland. Int J Cancer. 2002 Apr 20;98(6):912-5.

Holtorf K. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Postgraduate medicine. Jan 2009;121(1):73-85.

Horn-Ross PL, John EM, Canchola AJ, Stewart SL, Lee MM. Phytoestrogen intake and endometrial cancer risk. Journal of the National Cancer Institute. Aug 6 2003;95(15):1158-1164.

Hu FB. Overweight and obesity in women: health risks and consequences. J Womens Health (Larchmt). Mar 2003;12(2):163-172.

Huang CC, Orvis GD, Wang Y, Behringer RR. Stromal-to-epithelial transition during postpartum endometrial regeneration. PloS one. 2012;7(8):e44285.

Hung CM, Garcia-Haro L, Sparks CA, Guertin DA. mTOR-dependent cell survival mechanisms. Cold Spring Harb Perspect Biol. 2012 Dec 1;4(12).

Ishimi Y. Soybean isoflavones in bone health. Forum Nutr. 2009;61:104-16.

Jackman KA, Woodman OL, Sobey CG. Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights. Curr Med Chem. 2007;14(26):2824-30.

Janku F, Wheler JJ, Westin SN, Moulder SL, Naing A, Tsimberidou AM, . . . Kurzrock R. PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. J Clin Oncol. Mar 10 2012;30(8):777-782.

Je Y, Hankinson SE, Tworoger SS, DeVivo I, Giovannucci E. A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Dec 2011;20(12):2487-2495.

Jeong NH, Song ES, Lee JM, Lee KB, Kim MK, Cheon JE, . . . Kwon YI. Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer. Acta obstetricia et gynecologica Scandinavica. 2009;88(4):457-462.

Jick H, Walker AM, Rothman KJ. The epidemic of endometrial cancer: a commentary. Am J Public Health. 1980 Mar;70(3):264-7.

Jiralerspong S, Gonzalez-Angulo AM, Hung MC. Expanding the arsenal: metformin for the treatment of triple-negative breast cancer? Cell cycle (Georgetown, Tex.). Sep 1 2009;8(17):2681.

Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, . . . Gonzalez-Angulo AM. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol. Jul 10 2009;27(20):3297-3302.

Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease.Nature. 2013 Jan 17;493(7432):338-45.

Jung B, Ahmad N. Melatonin in cancer management: progress and promise. Cancer research. Oct 15 2006;66(20):9789-9793.

Juretzka MM, Chi DS, Sonoda Y. Update on surgical treatment for endometrial cancer. Expert Rev Anticancer Ther. Feb 2005;5(1):113-121.

Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Dec 2002;11(12):1531-1543.

Kaiser Permanente. What is a laparoscopic hysterectomy? [undated]. Available at: http://mydoctor.kaiserpermanente.org/ncal/facilities/region/eastbay/area_master/departments/laparoscopy/laparoscopy_gyn/laparoscopic_hysterectomy.jsp. Accessed 8/30/2013.

Kakuta Y, Nakaya N, Nagase S, Fujita M, Koizumi T, Okamura C, . . . Tsuji I. Case-control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma. Cancer causes & control : CCC. Jul 2009;20(5):617-624.

Kallianpur AR, Lee SA, Xu WH, Zheng W, Gao YT, Cai H, Ruan ZX, Xiang YB, Shu XO. Dietary iron intake and risk of endometrial cancer: a population-based case-control study in Shanghai, China. Nutr Cancer. 2010;62(1):40-50.

Kang S, Dong SM, Kim BR, et al. Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells. Apoptosis. 2012 Sep;17(9):989-97.

Katoh M, Nakagama H. FGF Receptors: Cancer Biology and Therapeutics. Med Res Rev. 2013 May 21. doi: 10.1002/med.21288. [Epub ahead of print]

Kaunitz AM. Long-acting injectable contraception with depot medroxyprogesterone acetate. Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1543-9.

Kawana K, Yamada M, Jimbo H, et al. Diagnostic usefulness of endometrial aspiration cytology for endometrial cancer cases with normal cutterage findings. Acta Cytol. 2005 Sep-Oct;49(5):507-12.

Kim HJ, Kim TJ, Lee YY, et al. A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system. J Gynecol Oncol. 2013 Apr;24(2):120-7.

Kojima T, Tanaka T, Mori H. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer research. Mar 15 1994;54(6):1446-1449.

Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS. Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer. Jun 15 2009;115(12):2765-2774.

Kristensen G, Tropé C. Endometrial cancer: the management of high-risk disease. Current Oncology Reports. 2004;6(6):471-475.

Kuiper C, Molenaar IG, Dachs GU, Currie MJ, Sykes PH, Vissers MC. Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer. Cancer research. Jul 15 2010;70(14):5749-5758.

Lai GY, Park Y, Hartge P, Hollenbeck AR, Freedman ND. The Association Between Self-Reported Diabetes and Cancer Incidence in the NIH-AARP Diet and Health Study. The Journal of clinical endocrinology and metabolism. Feb 13 2013.

Larkin T, Price WE, Astheimer L. The key importance of soy isoflavone bioavailability to understanding health benefits. Crit Rev Food Sci Nutr. 2008 Jun;48(6):538-52.

Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. The American journal of clinical nutrition. Jun 2004;79(6):935-945.

Laschke MW, Schwender C, Scheuer C, et al. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.Hum Reprod. 2008 Oct;23(10):2308-18.

Laviano A, Rianda S, Molfino A, Rossi Fanelli F. Omega-3 fatty acids in cancer. Current opinion in clinical nutrition and metabolic care. Mar 2013;16(2):156-161.

Lee LR, Teng PN, Nguyen H, Hood BL, Kavandi L, Wang G, . . . Syed V. Progesterone enhances calcitriol antitumor activity by upregulating vitamin d receptor expression and promoting apoptosis in endometrial cancer cells. Cancer prevention research. Jul 2013;6(7):731-743.

Lee WL, Lee FK, Su WH, Tsui KH, Kuo CD, Hsieh SL, Wang PH. Hormone therapy for younger patients with endometrial cancer. Taiwanese journal of obstetrics & gynecology. Dec 2012;51(4):495-505.

Lentz GM, Lobo RA, Gershenson DM, et al. Comprehensive Gynecology: Expert Consult – Online and Print, Sixth Edition, 32, 713-730, 2012.

Leong H, Firestone GL, Bjeldanes LF. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression. Carcinogenesis. Nov 2001;22(11):1809-1817.

Levi F, Franceschi S, Negri E, La Vecchia C. Dietary factors and the risk of endometrial cancer. Cancer. Jun 1 1993;71(11):3575-3581.

Lewandowski G, Torrisi J, Potkul RK, et al. Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer: a comparison of complication rates. Gynecol Oncol. 1990;36(3):401-4.

Lewis GC, Jr., Slack NH, Mortel R, Bross ID. Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer. Gynecologic oncology. Aug 1974;2(2-3):368-376.

Li X, Kumar A, Zhang F, Lee C, Li Y, Tang Z, Arjuna P. VEGF-independent angiogenic pathways induced by PDGF-C. Oncotarget. 2010 Aug;1(4):309-314.

Liberko M, Kolostova K, Bobek V. Essentials of circulating tumor cells for clinical research and practice. Critical reviews in oncology/hematology. Jul 4 2013.

Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocrine reviews. Feb 2000;21(1):40-54.

Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. Journal of pineal research. Aug 2003;35(1):12-15.

Lissoni P, Malugani F, Brivio F, Piazza A, Vintimilla C, Giani L, Tancini G. Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study. Neuro endocrinology letters. Jun-Aug 2003;24(3-4):259-262.

Llaurado M, Ruiz A, Majem B, Ertekin T, Colas E, Pedrola N, . . . Reventos J. Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease. Molecular and cellular endocrinology. Jul 25 2012;358(2):244-255.

Lodish H, Berk A, Zipursky SL, et al. New York: W. H. Freeman; 2000. Molecular Cell Biology. 4th Edition.

Lotze W, Richter P, Sarembe B. [High-dose progesterone therapy in advanced endometrial cancer]. Archiv fur Geschwulstforschung. 1982;52(7):569-574.

Lou H, Wu R, Fu Y. [Relation between selenium and cancer of uterine cervix]. Zhonghua zhong liu za zhi [Chinese journal of oncology]. Mar 1995;17(2):112-114.

Lu L, Risch H, Irwin ML, Mayne ST, Cartmel B, Schwartz P, . . . Yu H. Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer. International journal of cancer. Journal international du cancer. Sep 1 2011;129(5):1237-1243.

Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, . . . Zeleniuch-Jacquotte A. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. International journal of cancer. Journal international du cancer. Jan 20 2004;108(3):425-432.

Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, . . . Kaaks R. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. International journal of cancer. Journal international du cancer. Jan 10 2004;108(2):262-268.

Lymperatou D, Giannopoulou E, Koutras AK, et al. The exposure of breast cancer cells to fulvestrant and tamoxifen modulates cell migration differently. Biomed Res Int. 2013;2013:147514.

Mann GE, Bonacasa B, Ishii T, et al. Targeting the redox sensitive Nrf2-Kaep1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones. Curr Opin Pharmacol. 2009 Apr;9(2):139-45.

Mann GE, Rowlands DJ, Li FY, et al. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res. 2007 Jul 15;75(2):261-74.

Manohar M, Fatima I, Saxena R, et al. (-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation. J Nutr Biochem. 2013 Jun;24(6):940-7.

Mateos-Aparicio I, Redondo Cuenca A, Villanueva-Suarez MJ, et al. Soybean, a promising health source. Nutr Hosp. 2008 Jul-Aug;23(4):305-12.

MayoClinicStaff. Mayo Clinic. Endometrial Cancer; Tests and diagnosis. Available at: http://www.mayoclinic.com/health/endometrial-cancer/DS00306/DSECTION=tests-and-diagnosis. 2013.

McCann SE, Freudenheim JL, Marshall JR, Brasure JR, Swanson MK, Graham S. Diet in the epidemiology of endometrial cancer in western New York (United States). Cancer causes & control : CCC. Dec 2000;11(10):965-974.

McCarty MF. Isoflavones made simple – genistein’s agonist activity for the beta-type estrogen receptor mediates their health benefits. Med Hypotheses. 2006;66(6):1093-114.

McCullough ML, Bandera EV, Moore DF, Kushi LH. Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Preventive medicine. Apr 2008;46(4):298-302.

McTiernan A, Irwin M, Vongruenigen V. Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Sep 10 2010;28(26):4074-4080.

Melamed M, Castano E, Notides AC, Sasson S. Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol. Molecular endocrinology (Baltimore, Md.). Nov 1997;11(12):1868-1878.

Michnovicz JJ, Adlercreutz H, Bradlow HL. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. Journal of the National Cancer Institute. May 21 1997;89(10):718-723.

Micke O, Schomburg L, Buentzel J, et al. Selenium in oncology: from chemistry to clinics. Molecules. 2009;14(10):3975-88.

Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kurman RJ. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol. Apr 2002;186(4):651-657.

Moreno-Bueno G, Sánchez-Estévez C, Cassia R, et al. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res. 2003 Sep 15;63(18):5697-702.

Morotti M, Valenzano Menada M, Venturini PL, Ferrero S. Bevacizumab in endometrial cancer treatment. Expert Opin Biol Ther. May 2012;12(5):649-658.

Morrison C, Zanagnolo V, Ramirez N, Cohn DE, Kelbick N, Copeland L, Maxwell GL, Fowler JM. HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients. J Clin Oncol. 2006 May 20;24(15):2376-85.

Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG. Tamoxifen treatment and gynecologic side effects: a review. Obstetrics and gynecology. May 2001;97(5 Pt 2):855-866.

Mu N, Zhu Y, Wang Y, Zhang H, Xue F. Insulin resistance: a significant risk factor of endometrial cancer. Gynecol Oncol. Jun 2012;125(3):751-757.

Mulvey L, Chandrasekaran A, Liu K, et al. Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines. Mol Med. 2007 Jan-Feb;13(1-2):69-78.

Mutter GL. Endometrial intraepithelial neoplasm (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol. 2000;76(3):287-90.

Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. International journal of radiation oncology, biology, physics. Aug 1 2000;48(1):201-211.

Nagpal S, Chandraratna RA. Vitamin A and regulation of gene expression. Current opinion in clinical nutrition and metabolic care. Jul 1998;1(4):341-346.

Nakamura K, Hongo A, Kodama J, Hiramatsu Y. Fat accumulation in adipose tissues as a risk factor for the development of endometrial cancer. Oncology reports. Jul 2011;26(1):65-71.

Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med. Jan 2008;26(1):62-71.

NCI. National Cancer Institue (NCI). What you need to know about Cancer of the Uterus; Diagnosis. Available at: http://www.cancer.gov/cancertopics/wyntk/uterus/page6. 2010. Accessed 8/28/2013.

NCI. National Cancer Institute (NCI). Stages of Endometrial Cancer. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/endometrial/Patient/page2. Last updated 6/18/2013. Accessed 8/28/2013.

Negin BP, Cohen SJ. Circulating tumor cells in colorectal cancer: past, present, and future challenges. Curr Treat Options Oncol. 2010 Jun;11(1-2):1-13.

Nelson LR, Bulun SE. Estrogen production and action. J Am Acad Dermatol. 2001 Sep;45(3 Suppl):S116-24.

Neven P and Vernaeve H. Guidelines for Monitoring Patients Taking Tamoxifen Treatment. Drug Saf. 2000;22(1):1-11.

Nguyen H, Ivanova VS, Kavandi L, Rodriguez GC, Maxwell GL, Syed V. Progesterone and 1,25-dihydroxyvitamin D(3) inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F. Molecular cancer research : MCR. Nov 2011;9(11):1479-1492.

Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010 Mar 6;375(9717):816-23.

Nussler NC, Reinbacher K, Shanny N, et al. Sex-specific differences in the expression levels of estrogen receptor subtypes in coloectal cancer. Gend Med. 2008 Sep;5(3):209-17.

Odagiri T, Watari H, Hosaka M, Mitamura T, Konno Y, Kato T, . . . Sakuragi N. Multivariate survival analysis of the patients with recurrent endometrial cancer. J Gynecol Oncol. Mar 31 2011;22(1):3-8.

Ohno S, Sumiyoshi Y, Hashine K, Shirato A, Kyo S, Inoue M. Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission. Evidence-based complementary and alternative medicine : eCAM. 2011;2011:192381.

Ollberding NJ, Lim U, Wilkens LR, Setiawan VW, Shvetsov YB, Henderson BE, . . . Goodman MT. Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study. Journal of the National Cancer Institute. Jan 4 2012;104(1):67-76.

Oza AM, Elit L, Tsao MS, Kamel-Reid S, Biagi J, Provencher DM, . . . Eisenhauer EA. Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Aug 20 2011;29(24):3278-3285.

Parajuli B, Shin SJ, Kwon SH, Cha SD, Lee HG, Bae I, Cho CH. The synergistic apoptotic interaction of Indole-3-Carbinol and Genistein with TRAIL on endometrial cancer cells. Journal of Korean medical science. Apr 2013;28(4):527-533.

Park JY, Kim DY, Kim TJ, Kim JW, Kim JH, Kim YM, Kim YT, Bae DS, Nam JH. Hormonal therapy for women with stage IA endometrial cancer of all grades. Obstet Gynecol. 2013 Jul;122(1):7-14.

Peach G, Kim C, Zacharakis E, et al. Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review.Br J Cancer. 2010 Apr 27;102(9):1327-34.

Pelucchi C, Dal Maso L, Montella M, Parpinel M, Negri E, Talamini R, . . . La Vecchia C. Dietary intake of carotenoids and retinol and endometrial cancer risk in an Italian case-control study. Cancer causes & control : CCC. Dec 2008;19(10):1209-1215.

Plataniotis G, Castiglione M, ESMO Guidelines Working Group. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May;21 Suppl 5:v41-5.

Pocobelli G, Doherty JA, Voigt LF, Beresford SA, Hill DA, Chen C, . . . Weiss NS. Pregnancy history and risk of endometrial cancer. Epidemiology (Cambridge, Mass.). Sep 2011;22(5):638-645.

Punnonen R, Mattila J, Kuoppala T, Koivula T. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma. J Cancer Res Clin Oncol. 1993;119(7):426-429.

Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol. Jun 2001;15(3):341-354.

Rahaman J and Cohen CJ. Gynecologic Sarcomas. In Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine. 6h Edition. Chapter 120. Hamilton (ON): BC Decker; 2003. <http://www.ncbi.nlm.nih.gov/books/NBK13954/>

Rahbari NN, Bork U, Kircher A, Nimitz T, Schölch S, Kahlert C, Schmidt T, Steinert G, Ulrich AB, Reissfelder C, Büchler MW, Koch M, Weitz J. Compartmental differences of circulating tumor cells in colorectal cancer.Ann Surg Oncol. 2012 Jul;19(7):2195-202.

Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, . . . Gynecologic Oncology Group S. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Jan 1 2006;24(1):36-44.

Rüdiger N, Stein EL, Schill E, et al. Chemosensitivity Testing of Circulating Epithelial Tumor Cells (CETC) in Vitro: Correlation to in Vivo Sensitivity and Clinical Outcome. J Cancer Therapy 2013, 4:597-605.

Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. Bmj. Dec 1 2007;335(7630):1134.

Reiter RJ. Mechanisms of cancer inhibition by melatonin. Journal of pineal research. Oct 2004;37(3):213-214.

Rimbach G, Boesch-Saadatmandi C, Frank J, et al. Dietary isoflavones in the prevention of cardiovascular disease—a molecular perspective. Food Chem Toxicol. 2008 Apr;46(4):1308-19.

Rosenblatt PL. The Merck Manual. Menstrual Cycle. Available at:  http://www.merckmanuals.com/home/womens_health_issues/biology_of_the_female_reproductive_system/menstrual_cycle.html. Last updated July 2007. Accessed 8/28/2013.  

Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Journal of the National Cancer Institute. Feb 16 2000;92(4):328-332.

Rudolf E, Rudolf K, Cervinka M. Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells. Cell Biol Toxicol. 2008;24(2):123-41.

Sainz RM, Mayo JC, Tan DX, et al. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate. 2005 Apr 1;63(1):29-43.

Salazar-Martinez E, Lazcano-Ponce E, Sanchez-Zamorano LM, Gonzalez-Lira G, Escudero DELRP, Hernandez-Avila M. Dietary factors and endometrial cancer risk. Results of a case-control study in Mexico. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. Sep-Oct 2005;15(5):938-945.

Sanchez-Barcelo EJ, Cos S, Mediavilla D, Martinez-Campa C, Gonzalez A, Alonso-Gonzalez C. Melatonin-estrogen interactions in breast cancer. Journal of pineal research. May 2005;38(4):217-222.

Santin AD, Bellone S, Roman JJ, McKenney JK, Pecorelli S. Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu. Int J Gynaecol Obstet. Aug 2008;102(2):128-131.

Saydmohammed M, Joseph D, Syed V. Curcumin suppresses constitutive activation of STAT-3 up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells. J Cell Biochem. 2010;110(2):447-56.

Schiavone MB, Bashir S, Herzog TJ. Biologic therapies and personalized medicine in gynecologic malignancies. Obstet Gynecol Clin North Am. 2012 Jun;39(2):131-44.

Schmandt RE, Iglesias DA, Co NN, Lu KH. Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol. Dec 2011;205(6):518-525.

Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. Journal of the National Cancer Institute. Nov 3 2004;96(21):1635-1638.

Sexton E, Van Themsche C, LeBlanc K, et al. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol Cancer. 2006;5:45.

Shah YM, Al-Dhaheri M, Dong Y, Ip C, Jones FE, Rowan BG. Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells. Molecular cancer therapeutics. Aug 2005;4(8):1239-1249.

Shehzad A, Khan S, Sup Lee Y. Curcumin molecular targets in obesity and obesity-related cancers. Future Oncol. 2012;8(2):179-90.

Shimada M, Kigawa J, Terakawa N, et al. Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer. Int J Gynecol Cancer. 2007 Jan-Feb;17(1):210-4.

Shweel MA, Abdel-Gawad EA, Abdel-Gawad EA, et al. Uterine cervical malignancy: diagnostic accuracy of MRI with histopathologic correlation. J Clin Imag Sci. 2012;2:42.

Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, . . . Lu KH. Her-2/neu overexpression and amplification in uterine papillary serous carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Aug 1 2004;22(15):3126-3132.

Slomovitz BM, Coleman RL. The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer.  Clin Cancer Res. 2012 Nov 1;18(21):5856-64.

Smiraglia DJ, Smith LT, Lang JC, et al. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet. 2003 Jan; 40(1):25-33.

Smolarek AK, So JY, Thomas PE, Lee HJ, Paul S, Dombrowski A, . . . Suh N. Dietary tocopherols inhibit cell proliferation, regulate expression of ERalpha, PPARgamma, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia. Mol Carcinog. 2013 Jul;52(7):514-25.

Soliman PT, Cui X, Zhang Q, Hankinson SE, Lu KH. Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study. Am J Obstet Gynecol. Feb 2011;204(2):167.e161-165.

Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, . . . Lu KH. Risk factors for young premenopausal women with endometrial cancer. Obstetrics and gynecology. Mar 2005;105(3):575-580.

Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, . . . Lu KH. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer. Jun 1 2006;106(11):2376-2381.

Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Cardinali DP. Therapeutic actions of melatonin in cancer: possible mechanisms. Integr Cancer Ther. Sep 2008;7(3):189-203.

Suh DH, Kim JW, Kim K, Kim HJ, Lee KH. Major clinical research advances in gynecologic cancer in 2012. J Gynecol Oncol. Jan 2013;24(1):66-82.

Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study G. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. Journal of the National Cancer Institute. Mar 2 2005;97(5):375-384.

Takahashi K, Okada M, Ozaki T, Kurioka H, Manabe A, Kanasaki H, Miyazaki K. Safety and efficacy of oestriol for symptoms of natural or surgically induced menopause. Human reproduction (Oxford, England). May 2000;15(5):1028-1036.

Tang NP, Li H, Qui YL, et al. Tea consumption and risk of endometrial cancer: a metaanalysis. Am J Obstet Gynecol. 2009;201(6):605.e1-8.

Tang YZ, Liu ZQ. Chemical kinetic behavior of chlorogenic acid in protecting erythrocyte and DNA against radical-induced oxidation. J Agric Food Chem. 2008;56(22):11025-9.

Tannus SR, Atlas I. Endometrial cancer presenting as acute urinary retention: a case report and review of the literature. Cases J. 2009 Dec 22;2:9382.

Tao MH, Freudenheim JL. DNA methylation in endometrial cancer. Epigenetics. 2010 Aug 16;5(6):491-8.

Tao MH, Xu WH, Zheng W, Gao YT, Ruan ZX, Cheng JR, . . . Shu XO. A case-control study in Shanghai of fruit and vegetable intake and endometrial cancer. British journal of cancer. Jun 6 2005;92(11):2059-2064.

Terry P, Baron JA, Weiderpass E, Yuen J, Lichtenstein P, Nyren O. Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. International journal of cancer. Journal international du cancer. Jul 2 1999;82(1):38-42.

Terry P, Vainio H, Wolk A, Weiderpass E. Dietary factors in relation to endometrial cancer: a nationwide case-control study in Sweden. Nutrition and cancer. 2002;42(1):25-32.

Terry P, Wolk A, Vainio H, Weiderpass E. Fatty fish consumption lowers the risk of endometrial cancer: a nationwide case-control study in Sweden. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Jan 2002;11(1):143-145.

The Merck Manual. Endometrial Cancer. The Merck Manual online version. Available at: http://www.merckmanuals.com/professional/gynecology_and_obstetrics/gynecologic_tumors/endometrial_cancer.html. Last updated 5/2013. Accessed 8/21/2013.

Tong T, Yajia G, Huaying W, et al. Application of 1.5 T magnetic resonance imaging in endometrial cancer. Arch Gynecol Obstet. 2012;285(4):1113-8.

Traber MG, Stevens JF. Vitamins C and E: beneficial effects from a mechanistic perspective. Free radical biology & medicine. Sep 1 2011;51(5):1000-1013.

Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D. Cancer and Mediterranean dietary traditions. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Sep 2000;9(9):869-873.

Tunnicliffe JM, Shearer J. Coffee, glucose homeostatis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab. 2008 Dec;33(6):1290-1300.

Turner RT, Wakley GK, Hannon KS, et al. Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats. J Bone Miner Res. 1987 Oct; 2(5):449-56.

USDA  (U.S. Department of Agriculture). USDA National Nutrient Database for Standard Reference, Release 24. Available at: http://www.nutrition.gov/whats-food/vitamins-minerals/individual-vitamins. Last updated 8/26/2013. Accessed 8/28/2013.

Ushijima K, Yahata H, Yoshikawa H, et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. Journal of Clinical Oncology. 2007;25(19):2798–2803.

van Dijk AE, Olthof MR, Meeuse JC, et al. Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance.Diabetes Care. 2009 Jun;32(6):1023-5.

Vooijs GP, Geurts TB. Review of the endometrial safety during intravaginal treatment with estriol. European journal of obstetrics, gynecology, and reproductive biology. Sep 1995;62(1):101-106.

Vorvick LJ, Zieve D. MedlinePlus website; uterus. Updated 2/26/2012. Available at: http://www.nlm.nih.gov/medlineplus/ency/imagepages/19263.htm. Accessed 8/30/20123.

Wang S, Liu K, Liu J, et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angew Chem Int Ed Engl. 2011 Mar 21;50(13):3084-8.

Weiderpass E, Baron JA, Adami HO, Magnusson C, Lindgren A, Bergstrom R, . . . Persson I. Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet. May 29 1999;353(9167):1824-1828.

Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer causes & control : CCC. Feb 2000;11(2):185-192.

Weiss NS, Szekely DR, Austin DF. Increasing incidence of endometrial cancer in the United States. The New England journal of medicine. Jun 3 1976;294(23):1259-1262.

Westin SN, Broaddus RR. Personalized therapy in endometrial cancer: challenges and opportunities. Cancer Biol Ther. Jan 1 2012;13(1):1-13.

Williams CJ, Fargnoli JL, Hwang JJ, van Dam RM, Blackburn GL, Hu FB, Mantzoros CS. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes care. Mar 2008;31(3):504-507.

Wood CE, Register TC, Franke AA, et al. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res. 2006 Jan 15;66(2):1241-9.

Woodruff JD, Pickar JH. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group. Am J Obstet Gynecol. May 1994;170(5 Pt 1):1213-1223.

Wright JD, Barrena Medel NI, Sehouli J, Fujiwara K, Herzog TJ. Contemporary management of endometrial cancer. Lancet. Apr 7 2012;379(9823):1352-1360.

Wu T, Willett WC, Hankinson SE, Giovannucci E. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes care. Jun 2005;28(6):1390-1396.

Wulfing P, Borchard J, Buerger H, Heidl S, Zanker KS, Kiesel L, Brandt B. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research. Mar 15 2006;12(6):1715-1720.

Wynder EL, Escher GC, Mantel N. An epidemiological investigation of cancer of the endometrium. Cancer. Apr 1966;19(4):489-520.

Xiao CW. Health effects of soy protein and isoflavones in humans. J Nutr. 2008 Jun;138(6):1244S-9S.

Xie Y, Wang YL, Yu L, Hu Q, Ji L, Zhang Y, Liao QP. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells. J Steroid Biochem Mol Biol. Sep 2011;126(3-5):113-120.

Xu WH, Dai Q, Xiang YB, Zhao GM, Ruan ZX, Cheng JR, . . . Shu XO. Nutritional factors in relation to endometrial cancer: a report from a population-based case-control study in Shanghai, China. International journal of cancer. Journal international du cancer. Apr 15 2007;120(8):1776-1781.

Xu WH, Zheng W, Xiang YB, Ruan ZX, Cheng JR, Dai Q, . . . Shu XO. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. Bmj. May 29 2004;328(7451):1285.

Yang S, Thiel KW, De Geest K, et al. Endometrial cancer: reviving progesterone therapy in the molecular age. Discov Med. 2011;12(64):205-12.

Yeh M, Moysich KB, Jayaprakash V, Rodabaugh KJ, Graham S, Brasure JR, McCann SE. Higher intakes of vegetables and vegetable-related nutrients are associated with lower endometrial cancer risks. The Journal of nutrition. Feb 2009;139(2):317-322.

Yu M, Stott S, Toner M, et al. Circulating tumor cells: approaches to isolation and characterization.J Cell Biol. 2011 Feb 7;192(3):373-82.

Yu Y, Bae S, Kim H, et al. The Anti-tumor Activity of Vitamin C via the Increase of Fas (CD95) and MHC I Expression on Human Stomach Cancer Cell Line, SNU1. Immune Netw. 2011 Aug;11(4):210-5.

Yu Z, Shah DM. Curcumin down-regulates Ets-1 and Bcl-2 expression in human endometrial carcinoma HEC-1-A cells. Gynecol Oncol. 2007;106(3):541-8.

Zagouri F, Bozas G, Kafantari E, Tsiatas M, Nikitas N, Dimopoulos MA, Papadimitriou CA. Endometrial cancer: what is new in adjuvant and molecularly targeted therapy? Obstet Gynecol Int. 2010;2010:749579.

Zhang H, Gao C, Fang L, Zhao HC, Yao SK. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scand J Gastroenterol. Jan 2013;48(1):78-87.

Zhang P, Li H, Tan X, Chen L, Wang S. Association of metformin use with cancer incidence and mortality: A meta-analysis. Cancer Epidemiol. Jan 23 2013.

Zhang Z, Dong L, Sui L, Yang Y, Liu X, Yu Y, . . . Feng Y. Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. Feb 2011;21(2):213-221.

Zhang ZH, Su PY, Hao JH, Sun YH. The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies. Int J Gynecol Cancer. Feb 2013;23(2):294-303.

Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. The New England journal of medicine. Dec 4 1975;293(23):1167-1170.